Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Heart and Vessels

Search In Journal Title:

Abbravation: Heart and Vessels

Search In Journal Abbravation:

Publisher

Springer-Verlag

Search In Publisher:

DOI

10.1007/978-3-662-45643-9_48

Search In DOI:

ISSN

1615-2573

Search In ISSN:
Search In Title Of Papers:

Forearm vasoconstriction during dynamic leg exerci

Authors: John J Atherton Laurence G Dryburgh Helen L Thomson Thomas D Moore Karen N Wright Gerry W F Muehle Loretta E Fitzpatrick Michael P Frenneaux
Publish Date: 2012/09/14
Volume: 13, Issue: 6, Pages: 278-289
PDF Link

Abstract

Previous studies assessing vascular responses in nonexercising beds during exercise in patients with chronic heart failure CHF have yielded varying results We proposed that the clinical and hemodynamic severity of heart failure may explain some of the variation We reasoned that diastolic ventricular interaction DVI by limiting the ability of such patients to increase left ventricular LV volume and stroke volume during exercise would attenuate baroreflex activation resulting in increased sympathetic activation and hence exaggerated vasoconstriction We hypothesized therefore that vasoconstriction in nonexercising beds would be exaggerated in patients with symptomatic and hemodynamically severe heart failure particularly if associated with DVIWe measured forearm vascular resistance FVR during semierect cycle exercise in 22 CHF patients and 23 control subjects DVI was assessed by measuring changes in ventricular volumes radionuclide ventriculography during volume unloading −30 mmHg lowerbody negative pressure in the heart failure patients and was inferred when LV enddiastolic volume paradoxically increasedPatients with symptoms of heart failure developed larger increases in FVR during exercise than did asymptomatic patients There were significant correlations between the change in FVR during peak exercise and the resting mean pulmonary arterial pressure and pulmonary vascular resistance CHF patients with DVI developed exaggerated increases in FVR median 25th to 75th percentile compared with the remaining patients during lowworkload exercise 138 66 to 171 vs 64 −43 to 28 units P = 0002 and during peak exercise 160 90 to 384 vs 61 −74 to 75 units P 002Vasoconstriction in nonexercising beds is exaggerated in CHF patients with clinically and hemodynamically severe heart failure particularly if associated with DVI This may explain some of the reported variation in the degree of sympathetic activation that occurs during exercise in CHF patients


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Ox-LDL can enhance the interaction of mice natural killer cells and dendritic cells via the CD48-2B4 pathway
  2. Overlapping implantation of bioresorbable novolimus-eluting scaffolds: an observational optical coherence tomography study
  3. Level of urinary liver-type fatty acid-binding protein is associated with cardiac markers and electrocardiographic abnormalities in type-2 diabetes with chronic kidney disease stage G1 and G2
  4. Re-elevation of d -dimer as a predictor of re-dissection and venous thromboembolism after Stanford type B acute aortic dissection
  5. Gender differences in plaque characteristics of culprit lesions in patients with ST elevation myocardial infarction
  6. Diagnostic accuracy of contrast echocardiography during adenosine stress for detection of abnormal myocardial perfusion: a prospective comparison with technetium-99 m sestamibi single-photon emission computed tomography
  7. Association between circulating FGF23, α-Klotho, and left ventricular diastolic dysfunction among patients with preserved ejection fraction
  8. Detection of coronary artery disease by free-breathing, whole heart coronary magnetic resonance angiography: our initial experience
  9. Real-time tracking of adipose tissue-derived stem cells with injectable scaffolds in the infarcted heart
  10. Early sign of atherosclerosis in slow coronary flow and relationship with angiotensin-converting enzyme I/D polymorphism
  11. Pathological autopsy of a patient that underwent a successful ablation of an electrical storm from the left ventricular summit
  12. Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries
  13. Comparison of pulse wave velocity assessed by three different techniques: Arteriograph, Complior, and Echo-tracking
  14. Impact of drug-eluting balloon (pre- or post-) dilation on neointima formation in de novo lesions treated by bare-metal stent: the IN-PACT CORO trial
  15. Copeptin constitutes a novel biomarker of degenerative aortic stenosis
  16. Effects on bone metabolism markers and arterial stiffness by switching to rivaroxaban from warfarin in patients with atrial fibrillation
  17. Sudden death due to aortic rupture in acromegaly
  18. Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry
  19. A novel phenylpyridazinone, T-3999, reduces the progression of autoimmune myocarditis to dilated cardiomyopathy
  20. Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction
  21. Percutaneous coronary intervention for unprotected left main disease in very high risk patients: safety of drug-eluting stents
  22. Characteristics of idiopathic ventricular tachycardia originating above the pulmonary valve
  23. Fluvastatin-induced reduction of oxidative stress ameliorates diabetic cardiomyopathy in association with improving coronary microvasculature
  24. Physical inactivity increases endostatin and osteopontin in patients with coronary artery disease
  25. Matrix metalloprotein-9 activation under cell-to-cell interaction between endothelial cells and monocytes: possible role of hypoxia and tumor necrosis factor-α
  26. Noninvasively assessed pulsatility of ascending aortic pressure waveform is associated with the presence of coronary artery narrowing
  27. Extended-release niacin/laropiprant improves endothelial function in patients after myocardial infarction

Search Result: